Integral Molecular
Philadelphia
About Integral Molecular
The objective of Integral Molecular is to create and utilize novel technologies that promote therapy discoveries against challenging protein targets. With more than 20 years of experience focusing on membrane proteins and antibodies, the company's solutions have helped over 400 companies in research, medication discovery, and vaccine development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.4M
- Last round: Grant (Oct 2024)
- Website: integralmolecular.com
- Phone: 215-966-6061
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/integral-molecular-92243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.